What Aptitude Health does

Aptitude Health is a privately held, healthcare-focused intelligence and engagement company serving pharmaceutical and biotechnology clients in the oncology and hematology therapeutic areas. The company is incorporated as Aptitude Health Holdings, LLC, headquartered in Atlanta, Georgia, with additional offices in London and The Hague, and operates through wholly owned subsidiaries including Aptitude Health BV, Aptitude Health UK Limited, Bamboo Medical Communications Limited, and Athena Medical PR Limited. Aptitude Health is majority-owned by Linden Capital Partners following a 2018-2021 investment, and its customer base spans 110+ life science companies and 190+ brand teams. The company states it has supported more than two-thirds of all newly approved oncology drugs in the last three years.

The core technology is the proprietary Axess Network, a global community of 6,500+ hematology and oncology experts comprising 890+ key opinion leaders, 4,300+ community treating physicians, and 600+ other physicians across 2,100+ community-based practices in all US states. This network powers four integrated solution pillars: Business Intelligence (the 360° Insights suite of reports including RECAP, EPICS, ONCOBOARD, PIVOT, CASES, CARE, CORE, DECODE), Real-World Evidence (iPROPEL Registry platform and OncoJourney events), Promotional Services (CONNEX programs and product theaters), and Medical Communications (Global Cancer Academies, HOLI clinical immersion programs, advisory services, and satellite symposia at ASCO, ESMO, ASH, EHA, SABCS, and WCLC). In February 2025 the company launched OncoClinicAI, an AI-powered patient case simulation platform that generates synthetic patient journeys and produces predictive analytics on treatment decisions.

The business model is enterprise B2B with direct field sales to pharmaceutical and biotech companies. Revenue is generated through subscription or contract-based business intelligence reports, professional services for medical communications and real-world evidence engagements, and promotional services connecting life science sponsors with target physicians. Pricing is quote-based with multi-year contract structures, and is not publicly disclosed. Customer segments include life science brand teams and the underlying HCP consultant community, and the company is GDPR-, CCPA-, and HIPAA-aware with EU and UK data compliance frameworks in place.

Name

Aptitude Health

Legal name

Aptitude Health Holdings, LLC

Website

https://aptitudehealth.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

Aptitude Health delivers evidence-based oncology and hematology insights and HCP engagement services to 110+ life science companies through its Axess Network of 6,500+ KOLs and community physicians, offering business intelligence, real-world evidence, medical communications, and promotional services across the US, UK, and EU.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Market Intelligence

NAICS

Medical and Diagnostic Laboratories (62151), Offices of Physicians (62111)

akta.pro primary industry

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Clinical Decision Support & Workflow Integration (EHR/oncology systems) (HLAAANAE)

Keywords

• Oncology market intelligence
• Real-world evidence solutions
• Medical communications services
• Healthcare professional engagement
• Life sciences consulting

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Business Intelligence Reports: Subscription-based or contract-based access to business intelligence reports covering all major tumor types and hematologic malignancies. Reports deliver complex analyses of real-world practices and actionable healthcare market research insights.
2. Medical Communications Services: Professional services including hematology and oncology clinical immersion programs (HOLI), advisory services, satellite symposia, and Global Cancer Academies sponsored by life science companies.
3. Real-World Evidence Solutions: Custom-designed registries and observational research studies, physician experience programs, and OncoJourney events generating patient-level data solutions for clinical and commercial strategies.
4. Promotional Services: CONNEX programs connecting life science companies with target oncologists and hematologists through product theaters, tabletop exhibits, and in-practice information-sharing events at Axess Network gatherings.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

Aptitude Health provides evidence-based insights and HCP (healthcare professional) engagement services for life science companies operating in oncology and hematology. Its core asset is the proprietary Axess Network of 6,500+ key opinion leaders, community oncologists, and hematologists, which powers four integrated solution pillars: Business Intelligence (360° Insights reports), Real-World Evidence (registries, observational research, OncoJourney events), Promotional Services (CONNEX programs, product theaters), and Medical Communications (Global Cancer Academies, HOLI training, satellite symposia).

Product overview

Aptitude Health is a multi-product health care intelligence company serving life science companies in oncology and hematology. The core offering is the Axess Network—a proprietary global network of 6,500+ key opinion leaders and community oncologists/hematologists—that powers four integrated solution pillars: Business Intelligence (360° Insights reports including RECAP, EPICS, ONCOBOARD, PIVOT, CASES, CARE, CORE, DECODE), Real-World Evidence (iPROPEL Registry, OncoJourney), Promotional Services (CONNEX programs), and Medical Communications (Global Cancer Academies, HOLI training programs). The company operates AI-powered OncoClinicAI for patient case simulation and has acquired brands including Targeted Medical Education/TME (Breast Care Network), Bamboo Medical Communications, and Athena Meetings & Events to expand capabilities and geographic reach.

Differentiator

Problem solved

Functional benefit

Brands

• Axess Network: Proprietary global network of key opinion leaders, health care providers, community oncologists and hematologists that shapes clinical innovation through unbiased collaboration with peers and life science companies.
• OncoClinicAI
• OncoJourney
• Global Breast Cancer Academy
• Global Leukemia Academy
• Global Multiple Myeloma Academy
• Global Lung Cancer Academy

Products and services

• Axess Network Proprietary global network of 6,500+ hematology and oncology experts (890+ KOLs, 4,300+ community treating physicians, and 600+ other physicians) across 2,100+ community-based practices in all US states, connecting life science companies with HCPs for advisory engagements, research, and promotional services.
• Business Intelligence (360° Insights) Suite of business intelligence reports and insights including RECAP, EPICS, ONCOBOARD, PIVOT, CASES, CARE, CORE, DECODE, and OncoClinicAI that deliver actionable insights and strategic recommendations for life science brand teams across all major tumor types and hematologic malignancies.
• Real-World Evidence Patient-level data solutions including custom registries, observational research studies, physician experience programs, and OncoJourney events that drive evidence-based clinical and commercial strategies for life science companies.
• Promotional Services Commercial engagement programs including CONNEX programs, product theaters, tabletop exhibits, and in-practice information-sharing events at Axess Network gatherings that maximize reach to high-priority oncologists and hematologists for life science sponsors.
• Medical Communications Comprehensive medical communications services including Global Cancer Academies (breast cancer, leukemia, multiple myeloma, lung cancer), HOLI clinical immersion programs, advisory services, satellite symposia at major conferences (ASCO, ESMO, ASH, EHA, SABCS, WCLC), and the annual Take the Lead in Breast Cancer Care summit.
• OncoClinicAI On-demand AI-powered patient case simulation platform that simulates real-world patient journeys, enabling HCPs to navigate complex treatment pathways from diagnosis to final therapy. Captures real-time treatment decisions across the continuum of care, with an interactive analytics dashboard analyzing how adverse events, peer comparisons, and KOL perspectives influence HCP decision-making.
• OncoJourney Immersive, expert-led experience integrating real-world data into peer-moderated discussions among practicing oncologists and hematologists inside health systems, surfacing the rationale behind clinical decisions and aligning stakeholders on improvement priorities.
• iPROPEL Registry Platform Custom-designed, fit-for-purpose registry platform for designing, implementing, and activating registries and observational research programs that generate high-quality real-world insights aligned to product development and commercialization objectives.
• Global Cancer Academies Virtual educational meetings featuring renowned clinical experts including the Global Breast Cancer Academy, Global Leukemia Academy, Global Multiple Myeloma Academy, and Global Lung Cancer Academy, broadening reach and awareness among treating physicians and sponsored by life science companies.
• HOLI Training Programs Hematology and Oncology Clinical Immersion (HOLI) training programs that improve internal team disease-state knowledge, IDN/health system understanding, launch preparedness, and strategic planning for life science company teams.
• DECODE Reports Business intelligence report product that gathers critical insights from influential community oncologists through 1-hour data collection events featuring pre/post polling, expert-led discussions, and surveys.

Quantifiable outcome

• >2/3 of all new approved oncology drugs were supported in the last 3 years
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core, major and supporting.

• Bamboo Medical Communications LtdcoreStrategic or Co-development Partner · 1 August 2023Acquisition of UK-based Bamboo Medical Communications Ltd to strengthen presence and service offerings in Europe. The integration aims to expand digital capabilities and healthcare professional network across the region, providing enhanced medical communication solutions.
• Targeted Medical Education (TME)coreStrategic or Co-development Partner · 1 August 2022Acquisition of TME and their Breast Care Network (BCN) in August 2022 to enhance oncology and breast care offerings. The merger aims to expand TME's reach and improve patient outcomes through collaborations with clinicians and the life science industry. Accelerates development of Axess Network and fosters clinical collaboration.
• Athena Meetings & EventsmajorStrategic or Co-development Partner · 1 January 2022Acquisition of Athena Meetings & Events, organizer of the UK Oncology Forum, extends and strengthens global reach. Expands event management capabilities and oncology conference portfolio.
• HUG HealthsupportingStrategic or Co-development Partner · 1 January 2022Acquisition of HUG Health expands capabilities of Bamboo Medical portfolio company, enabling offering of fully integrated, end-to-end healthcare communications solutions.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• IQVIA: IQVIA is the largest healthcare data, analytics, and commercial insights provider globally, with dedicated oncology real-world evidence and HCP engagement offerings that directly overlap Aptitude Health's BI, RWE, and Promotional Services pillars.
• ZS Associates: ZS Associates runs a large oncology-focused commercial strategy and real-world evidence practice serving pharma brand teams, with deep KOL and community physician relationships comparable to the Axess Network.
• Evidera (PPD / Thermo Fisher Scientific): Evidera is a dedicated real-world evidence and market access consultancy for life sciences, providing patient-level data solutions and evidence generation that closely mirror Aptitude's iPROPEL registry and OncoJourney offerings.
• Trinity Life Sciences: Trinity Life Sciences offers strategy, insights, and evidence solutions for life sciences with strong oncology expertise, competing head-to-head for pharma brand-team market intelligence and KOL engagement work.
• Kantar Health: Kantar Health provides oncology and other therapeutic-area market research, real-world evidence, and commercial insights to life sciences, with a comparable mix of syndicated and custom deliverables to pharma clients.
• Cello Health (now part of Cipher Medical): Cello Health combines pharmaceutical insights, evidence, and medical communications services for life sciences companies — a directly comparable multi-pillar offering to Aptitude Health's BI, RWE, and Medical Communications pillars.
• Decision Resources Group (Clarivate): Decision Resources Group, part of Clarivate, delivers disease-level market intelligence, forecasts, and real-world data to pharma, overlapping with Aptitude's oncology business intelligence reports and RWE offerings.

Broad incumbents

• Parexel International: Parexel is a large global CRO that has expanded into real-world evidence, market access, and commercial services for pharma, providing broader-scale competition for oncology evidence generation engagements.
• Syneos Health: Syneos Health combines clinical development with commercial and medical affairs services for life sciences, including HCP engagement and evidence generation capabilities that compete with Aptitude's broader portfolio.
• Medscape (WebMD Health Corp): Medscape is a large healthcare professional engagement and medical education platform that overlaps with Aptitude's Global Cancer Academies, HOLI programs, and broader HCP community-led growth motion.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights6 records

Customer concentration

• Xx.com/aptitude_health
• Facebookfacebook.com/aptitudehealth
• LinkedInlinkedin.com/company/aptitude-health

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aptitude Health